These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 31314650)
1. Personalized Care in the Prevention of Treatment-Related Cardiac Dysfunction in Female Cancer Survivors. Pituskin E; Perri M; Cox-Kennett N; Andrews E; Dimitry R; McNeely M; Paterson I J Womens Health (Larchmt); 2019 Oct; 28(10):1384-1390. PubMed ID: 31314650 [No Abstract] [Full Text] [Related]
2. Cardiotoxicity among adult survivors suffered from childhood malignancies. Petropoulos AC; Moschovi M Hell J Nucl Med; 2019; 22 Suppl 2():34-40. PubMed ID: 31802042 [TBL] [Abstract][Full Text] [Related]
3. Educational paper: decreasing the burden of cardiovascular disease in childhood cancer survivors: an update for the pediatrician. Dillenburg RF; Nathan P; Mertens L Eur J Pediatr; 2013 Sep; 172(9):1149-60. PubMed ID: 23361962 [TBL] [Abstract][Full Text] [Related]
4. Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment. Chow EJ; Leger KJ; Bhatt NS; Mulrooney DA; Ross CJ; Aggarwal S; Bansal N; Ehrhardt MJ; Armenian SH; Scott JM; Hong B Cardiovasc Res; 2019 Apr; 115(5):922-934. PubMed ID: 30768157 [TBL] [Abstract][Full Text] [Related]
5. Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy. Virani SA; Dent S; Brezden-Masley C; Clarke B; Davis MK; Jassal DS; Johnson C; Lemieux J; Paterson I; Sebag IA; Simmons C; Sulpher J; Thain K; Thavendiranathan P; Wentzell JR; Wurtele N; Côté MA; Fine NM; Haddad H; Hayley BD; Hopkins S; Joy AA; Rayson D; Stadnick E; Straatman L Can J Cardiol; 2016 Jul; 32(7):831-41. PubMed ID: 27343741 [TBL] [Abstract][Full Text] [Related]
6. Long-term cardiovascular health in adult cancer survivors. Naaktgeboren WR; Linschoten M; de Graeff A; V Rhenen A; Cramer MJ; Asselbergs FW; Maas AHEM; Teske AJ Maturitas; 2017 Nov; 105():37-45. PubMed ID: 28583397 [TBL] [Abstract][Full Text] [Related]
7. Echocardiography and cancer therapeutics-related cardiac dysfunction. Tanaka H J Med Ultrason (2001); 2019 Jul; 46(3):309-316. PubMed ID: 31030300 [TBL] [Abstract][Full Text] [Related]
9. Cardiac Outcomes in Survivors of Pediatric and Adult Cancers. Nathan PC; Amir E; Abdel-Qadir H Can J Cardiol; 2016 Jul; 32(7):871-80. PubMed ID: 27179545 [TBL] [Abstract][Full Text] [Related]
10. Cardiooncology-dealing with modern drug treatment, long-term complications, and cancer survivorship. de Wall C; Bauersachs J; Berliner D Clin Exp Metastasis; 2021 Aug; 38(4):361-371. PubMed ID: 34117981 [TBL] [Abstract][Full Text] [Related]
11. [Cardiovascular complications of cancers and anti-cancer therapy]. Vyskočil J; Petráková K; Jelínek P; Furdek M Vnitr Lek; 2017; 63(3):200-209. PubMed ID: 28379023 [TBL] [Abstract][Full Text] [Related]
12. Echocardiography and Alternative Cardiac Imaging Strategies for Long-Term Cardiotoxicity Surveillance of Cancer Survivors Treated with Chemotherapy and/or Radiation Exposure. Garg V; Vorobiof G Curr Oncol Rep; 2016 Aug; 18(8):52. PubMed ID: 27461436 [TBL] [Abstract][Full Text] [Related]
13. [Cardiotoxicity of Cancer Chemotherapy - Mechanisms and Therapeutic Approach]. Akazawa H Gan To Kagaku Ryoho; 2017 Dec; 44(13):2058-2063. PubMed ID: 29361617 [TBL] [Abstract][Full Text] [Related]
14. Treatment of chemotherapy-associated cardiomyopathy. Cai AW; Taylor MH; Ramu B Curr Opin Cardiol; 2019 May; 34(3):296-302. PubMed ID: 30747732 [TBL] [Abstract][Full Text] [Related]
15. Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors. Sadurska E Pediatr Cardiol; 2015 Aug; 36(6):1112-9. PubMed ID: 25939787 [TBL] [Abstract][Full Text] [Related]
16. Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN). Pituskin E; Haykowsky M; McNeely M; Mackey J; Chua N; Paterson I BMC Cancer; 2016 Sep; 16(1):733. PubMed ID: 27629548 [TBL] [Abstract][Full Text] [Related]
17. Circulating biomarkers for management of cancer therapeutics-related cardiac dysfunction. Tonry C; Russell-Hallinan A; McCune C; Collier P; Harbinson M; Dixon L; Watson CJ Cardiovasc Res; 2023 May; 119(3):710-728. PubMed ID: 35640873 [TBL] [Abstract][Full Text] [Related]
18. Cancer Therapy-Related Cardiac Dysfunction: Strategies for Enhancing Cardiac Recovery. Martinez-Dominguez P; Ana-Bayona MJS; Guerra EC; Espinola-Zavaleta N Methodist Debakey Cardiovasc J; 2024; 20(4):109-112. PubMed ID: 39184162 [TBL] [Abstract][Full Text] [Related]
19. Cardiotoxicity of cancer chemotherapy: implications for children. Simbre VC; Duffy SA; Dadlani GH; Miller TL; Lipshultz SE Paediatr Drugs; 2005; 7(3):187-202. PubMed ID: 15977964 [TBL] [Abstract][Full Text] [Related]
20. Cardio-oncology, the myth of Sisyphus, and cardiovascular disease in breast cancer survivors. Mavrogeni SI; Sfendouraki E; Markousis-Mavrogenis G; Rigopoulos A; Noutsias M; Kolovou G; Angeli C; Tousoulis D Heart Fail Rev; 2019 Nov; 24(6):977-987. PubMed ID: 31134427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]